history of kras-targeting in clinical trials
Published 3 years ago • 280 plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
1:04
recent trials of kras targeting and the future
-
4:41
history of kras testing in advanced nsclc
-
1:25
challenges of kras-targeting for lung cancer therapy
-
4:09
a new era in targeting kras
-
1:02
targeting kras: future directions
-
2:26
targeting kras mutations in lung cancer
-
1:10
targeting non-g12c kras mutations in nsclc
-
2:55
audio described: clinical trial tests nivolumab for patients with rare brain and spine cancers
-
4:55
cutting edge clinical trials in metastatic cancer
-
5:29
accelerating lung cancer diagnoses through liquid biopsy
-
3:35
adding chemotherapy to immunotherapy in metastatic crc
-
0:49
targeting kras-driven nsclc
-
1:27
advances in the development of kras inhibitors
-
1:09
challenges in targeting krasg12c mutations
-
2:47
etop clinical trials in egfr-, krasg12c- and alk-mutated nsclc
-
0:47
the role of immunotherapy with kras inhibitors in kras-driven nsclc
-
5:16
mitigating resistance in kras-driven cancers
-
1:48
evaluating the effects of the opera trial in clinical practice
-
8:47
innovations within precision oncology: evolution of a biomarker—a case study of kras g12c